• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[199例多发性硬化症患者的病例研究:EDMUS程序的应用]

[Case study of 199 patients with multiple sclerosis: the use of EDMUS program].

作者信息

Bernet-Bernady P, Preux P M, Preux C, Dumas M, Vallat J M, Couratier P

机构信息

Service de Neurologie CHU de Limoges, Faculté de Médecine.

出版信息

Rev Neurol (Paris). 2000 Jan;156(1):41-6.

PMID:10693257
Abstract

European Database Multiple Sclerosis (EDMUS) is a standardized tool which allows the collection of clinical, biological, radiological and therapeutic data on multiple sclerosis (MS). A descriptive analysis of 199 patients was done using EDMUS (version 2.2). Most data agreed with previous published results, except a low 0.4 sex ratio. At the beginning of MS, 42 p. 100 of MS patients developed pyramidal and sensory involvements and 14 p. 100 retrobulbar optic neuritis. Optic neuritis was the most frequent initial symptom of relapsing-remitting MS (25.9 p. 100) but not in the chronic progressive form (5.5 p, 100; p < 0.01). Surprisingly, relapsing-remitting form occurred more frequently whereas the secondary progressive form was diagnosed less. The concordances between the three disability scales, EGS (EDMUS Grading Scale), EDSS (Expanded Disability Status Score) and AI (Hauser Ambulation Index) were correct. In clinical practice, EDMUS is user-friendly and rapid. The lack of radiological data and the necessary quantification of only one disability scale, EGS may be too restrictive. The analysis of most of clinical data is possible by using integrated selection within the software, but sometimes needs more complex procedures.

摘要

欧洲多发性硬化症数据库(EDMUS)是一种标准化工具,可用于收集多发性硬化症(MS)的临床、生物学、放射学和治疗数据。使用EDMUS(2.2版)对199例患者进行了描述性分析。除了性别比例低至0.4外,大多数数据与先前发表的结果一致。在MS发病初期,42%的MS患者出现锥体束和感觉受累,14%出现球后视神经炎。视神经炎是复发缓解型MS最常见的初始症状(25.9%),但在慢性进展型中并非如此(5.5%;p<0.01)。令人惊讶的是,复发缓解型更为常见,而继发进展型的诊断较少。三种残疾量表,即EGS(EDMUS分级量表)、EDSS(扩展残疾状态评分)和AI(豪泽步行指数)之间的一致性是正确的。在临床实践中,EDMUS用户友好且快速。缺乏放射学数据以及仅对一种残疾量表EGS进行必要的量化可能过于受限。通过使用软件中的综合选择可以对大多数临床数据进行分析,但有时需要更复杂的程序。

相似文献

1
[Case study of 199 patients with multiple sclerosis: the use of EDMUS program].[199例多发性硬化症患者的病例研究:EDMUS程序的应用]
Rev Neurol (Paris). 2000 Jan;156(1):41-6.
2
How effective are disease-modifying drugs in delaying progression in relapsing-onset MS?疾病修正药物在延缓复发型多发性硬化症进展方面的效果如何?
Neurology. 2007 Oct 9;69(15):1498-507. doi: 10.1212/01.wnl.0000271884.11129.f3. Epub 2007 Aug 15.
3
Natural history of multiple sclerosis: a unifying concept.多发性硬化症的自然史:一个统一的概念。
Brain. 2006 Mar;129(Pt 3):606-16. doi: 10.1093/brain/awl007. Epub 2006 Jan 16.
4
European validation of a standardized clinical description of multiple sclerosis.欧洲对多发性硬化症标准化临床描述的验证。
J Neurol. 2004 Dec;251(12):1472-80. doi: 10.1007/s00415-004-0567-0.
5
[Clinical assessment of the course of relapsing-remitting multiple sclerosis in patients treated with interferon beta].[干扰素β治疗复发缓解型多发性硬化症患者病程的临床评估]
Pol Merkur Lekarski. 2005 Nov;19(113):654-8.
6
Utilization of the multiple sclerosis functional composite in follow-up: relationship to disease phenotype, disability and treatment strategies.随访中多发性硬化功能综合指标的应用:与疾病表型、残疾及治疗策略的关系
J Neurol Sci. 2005 May 15;232(1-2):65-9. doi: 10.1016/j.jns.2005.01.008.
7
[EDMUS--a new European databank for multiple sclerosis. A brief introduction of ongoing and planned multicenter studies within the scope of the "European Concentrated Action for Multiple Sclerosis"].[欧洲多发性硬化症数据库(EDMUS)。“欧洲多发性硬化症集中行动”范围内正在进行和计划中的多中心研究简介]
Nervenarzt. 1996 Apr;67(4):277-82.
8
Use of low-dose mitozantrone to treat aggressive multiple sclerosis: a single-centre open-label study using patient self-assessment and clinical measures of multiple sclerosis status.使用低剂量米托蒽醌治疗侵袭性多发性硬化症:一项采用患者自我评估和多发性硬化症状态临床测量的单中心开放标签研究。
Intern Med J. 2005 Jul;35(7):382-7. doi: 10.1111/j.1445-5994.2005.00862.x.
9
Predictors of relapse rate in MS clinical trials.多发性硬化症临床试验中复发率的预测因素。
Neurology. 2005 Dec 13;65(11):1769-73. doi: 10.1212/01.wnl.0000187122.71735.1f.
10
Relapses and subsequent worsening of disability in relapsing-remitting multiple sclerosis.复发缓解型多发性硬化症的复发及随后残疾状况的恶化
Neurology. 2006 Sep 12;67(5):804-8. doi: 10.1212/01.wnl.0000234064.17156.03.